CTSO (cytosorbents.com) Net earnings per share growth this year

Official company branding of Cytosorbents (CTSO)

The proportional growth of EPS compared to last year demonstrates the results of Cytosorbents (CTSO) partnerships with hospitals and scientific centers for blood purification, where -72.80 shows the level of this metric. The unique CytoSorb system ensures leadership in sepsis treatment by removing excess cytokines. The company is currently developing a mature product line, expanding its clinical base and penetrating new medical niches.

CTSO (CytoSorbents Corp.) Earnings per share growth in current year history from 07/04/2022 to 11/11/2026

Financial and market metric breakdowns for cytosorbents.com (CTSO)

- current quotes and average value forecast:
Market Chart CytoSorbents Corporation|CTSO - Analyst Consensus Forecast
- business market valuation indicators:
Market Valuation CytoSorbents Corporation|CTSO - Real Price to Acquire Entire Company
- company book value details:
Accounting Value of a Share Cytosorbents|CTSO - Company Book Value|Market Cap to Net Assets Ratio cytosorbents.com|CTSO - Company Total Assets
- debt and solvency information:
Debt to Capital Cytosorbents|CTSO - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio CytoSorbents Corporation|CTSO - Company Aggregate Debts|Debts to Net Assets CytoSorbents Corporation|CTSO - Company Long-Term Debts|Company Current Liabilities Cytosorbents|Quick Ratio cytosorbents.com
- net income and valuation multiples indicators:
CTSO - Company Net Income|Expected Profit Cytosorbents|CTSO - Price to Earnings Ratio|Future Price to Earnings Multiple CytoSorbents Corporation|CTSO - PEG Multiple|Company Value to EBITDA CytoSorbents Corporation|CTSO - Profit before payment of interest, taxes and amortization|Net earnings per share for the trailing year Cytosorbents|CTSO - Net earnings per share for the last 12 months|Quarterly EPS earnings growth cytosorbents.com|CTSO - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Cytosorbents
Fundamental valuation:CTSO - CytoSorbents Corp.
Signature product of CytoSorbents Corp.

The efficiency of Cytosorbents (CTSO) expansion into new intensive care niches is reflected in the year-over-year EPS growth rate dynamics. This indicator measures the annual change in earnings per share, neutralizing the impact of infrequent financial reports through daily recalculation. Such a methodology allows for the filtering of random market noise from genuine fundamental progress. The steady rise of this metric confirms the commercial success of the CytoSorb technology, while the positive trend demonstrates the high resilience of the business model.

Direct competitors

DXCM - Expected net earnings per share growth this year|PEN (Penumbra Corp) - Earnings growth in current year|Net earnings per share growth this year Novanta Photonics (NOVT)|Net earnings per share growth this year HAE (Haemonetics Corporation)|INSP (inspiresleep.com) - Earnings per share increase in current year|Earnings per share growth in current year PROCEPT BioRobotics Corporation PRCT|CNMD - Net earnings per share growth this year|Pulse Corp - Earnings growth in current year|Earnings per share growth rate in current year InMode MD|PMI: Earnings growth in current year|Earnings per share growth this year SRDX|SENS (Senseonics Holdings, Inc.) - Earnings growth in current year|NeuroPace Inc (NPCE) - Expected net earnings per share growth this year|Earnings growth in current year TCMD|Net earnings per share growth this year SANUWAVE Health Inc SNWV|Earnings growth in current year OM (Outset Medical, Inc.)|Earnings growth in current year SmartVest ELMD|LNSR - Earnings per share growth in current year|RCEL: Earnings per share growth in current year|PROF (profoundmedical.com) - Net earnings per share growth this year|Baird Medical - Earnings per share increase in current year|EDAP (EDAP TMS SA) - Earnings growth in current year|Earnings per share growth rate in current year Bovie Medical APYX|Earnings per share growth in current year IceCure Medical Ltd (ICCM)|pulmonx.com (LUNG) - Net earnings per share change in current year|TELA Bio - Net earnings per share growth this year|Earnings growth in current year Sensus SRTS|Zynex, Inc. - Earnings growth in current year|Expected net earnings per share growth this year electroCore, Inc. ECOR|vicarioussurgical.com (RBOT) - Earnings per share growth in current year|Earnings per share trend in current year IINN (Inspira Technologies)|Earnings per share growth in current year SeaStar Medical Holding Corp|Net earnings per share growth this year IRIDEX Corp. (IRIX)|Earnings growth in current year INBS|XAIR - Earnings per share growth rate in current year|Earnings per share growth in current year Profusa PFSA|SSKN: Earnings per share growth this year|GCTK: Net earnings per share growth this year|nanovibronix.com - Net earnings per one share growth for the current year|VERO: Earnings growth in current year|Net earnings per share growth this year nuwellis.com|Net earnings per share growth this year AEMD|Earnings per share growth rate in current year TransEnterix ASXC|Net earnings per share growth this year AVGR (Avinger, Inc)|Net earnings per one share growth for the current year BSGM|Earnings per share growth in current year Cutera, Inc. CUTR|knowlabs.co (KNW) - Earnings per share growth rate in current year|NARI - Earnings per share growth in current year|Expected net earnings per share growth this year Nevro Corp NVRO|reshapelifesciences.com (RSLS) - Earnings per share growth in current year|Earnings per share growth rate in current year Silk Road Medical Inc (SILK)